Skip to main content

Bay Area biotechs soar on coattails of AstraZeneca cancer drug study

The companies have drugs in clinical trials that target an enzyme implicated in poor prognosis for patients.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.